arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Organogenesis Holdings Inc.

ORGO Health Care Biotechnology: Pharmaceutical Preparations
$0.99
▲ +0.2% Today
as of Oct 23, 16:51 ET
Last 30 days -31.33% Sep 14 → Oct 22
$0.95 $1.10 $1.25 $1.39 $1.54 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$1.02
High
$1.03
Low
$0.93
Volume
$1M
Avg Vol
$1M
Mkt Cap
$170M
P/E (TTM)
—
Beta
—
52w High
$7.08
52w Low
$0.93
Div Yield
—
Shares Out
$129M

Recent Press Releases & News last 60 days · 2 items

Oct 12 · 20:10 PR GlobeNewswire
Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers
Oct 12 · 20:05 PR GlobeNewswire
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026

ORGO earnings at a glance

Organogenesis Holdings Inc. (ORGO) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. The options market is pricing a move of about ±174.2% after the report, a range of roughly -$0.73 to $2.71 from today's $0.99. Over its last 4 reports the stock rose the next day 2 times and fell 2, moving ±23.6% on average; after the most recent report on May 7, 2026 it moved -6.3%. That means options currently expect more movement than ORGO has typically delivered. ORGO beat the consensus EPS estimate in 0 of its last 1 reported quarters. Implied volatility is currently 14%. The share price of $0.99 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.93
$7.08
1% of range
Avg surprise (last 1)
-425.0%
Avg reaction (last 4)
-0.9%
50% positive
Latest IV / EM
1391%
EM ±174.2% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.77$-0.53$-0.30$-0.06$0.18 Actual $-0.02Actual $0.04Actual $0.02Actual $-0.02Actual $-0.13Actual $0.09Actual $-0.13Est $0.04Actual $-0.09Actual $0.18Actual $-0.37Actual $-0.77 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-96M$-33M$31M$95M$158M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.77 — — — — financials
Thu May 7, 2026Mar/2026 $-0.37 — — -184.6% -6.3% earnings
Thu Nov 6, 2025Sep/2025 $0.18 — — — +44.7% earnings
Thu Aug 7, 2025Jun/2025 $-0.09 — — — +0.8% earnings
Thu May 8, 2025Mar/2025 $-0.13 $0.04 -425.0% — -42.7% earnings
Mon Sep 30, 2024Sep 2024 $0.09 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.13 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.02 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.02 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.04 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.02 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Nov 5, 2026Sep/2026OTHER —$0.18

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$44M$37M—$151M$101M$87M—$115M
Cost of revenue—————$24M—$27M
Gross profit—————$63M—$88M
Operating income$-51M$-69M—$21M$-13M$-27M—$6M
Net income$-96M$-53M—$22M$-9M$-19M—$12M
EPS (diluted)$-0.77$-0.44—$0.11$-0.10$-0.17—$0.09

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$46M$91M$94M$64M$73M$110M$136M$94M
Inventory$29M$28M$30M$40M$33M$29M$26M$27M
Total current assets$200M$269M$362M$300M$260M$268M$286M$239M
Total assets$406M$520M$599M$510M$461M$467M$498M$446M
Long-term debt———————$62M
Total liabilities$118M$139M$165M$124M$100M$99M$113M$168M
Total equity$148M$245M$300M$255M$233M$243M$263M$279M

Implied volatility — last 90 days

51%708%1365%2022%2679% Jun 19 — IV 195% · EM ±43.0%Jun 22 — IV 296% · EM ±61.7%Jun 23 — IV 131% · EM ±26.7%Jun 24 — IV 51% · EM ±10.2%Jun 25 — IV 158% · EM ±30.9%Jun 26 — IV 484% · EM ±92.6%Jun 29 — IV 70% · EM ±12.4%Jun 30 — IV 83% · EM ±14.3%Jul 01 — IV 86% · EM ±14.3%Jul 02 — IV 92% · EM ±14.8%Jul 03 — IV 95% · EM ±14.8%Jul 07 — IV 77% · EM ±10.2%Jul 09 — IV 86% · EM ±10.2%Jul 10 — IV 94% · EM ±10.4%Jul 28 — IV 106% · EM ±21.7%Jul 29 — IV 99% · EM ±19.8%Jul 30 — IV 115% · EM ±22.4%Jul 31 — IV 110% · EM ±21.1%Aug 04 — IV 98% · EM ±16.9%Aug 05 — IV 101% · EM ±16.8%Aug 06 — IV 128% · EM ±20.7%Aug 07 — IV 1755% · EM ±274.2%Aug 12 — IV 590% · EM ±73.9%Aug 13 — IV 686% · EM ±81.0%Aug 14 — IV 657% · EM ±72.6%Aug 18 — IV 1158% · EM ±83.8%Aug 20 — IV 1822% · EM ±76.1%Aug 24 — IV 444% · EM ±92.8%Aug 25 — IV 407% · EM ±83.3%Aug 26 — IV 399% · EM ±80.0%Aug 28 — IV 420% · EM ±80.5%Aug 31 — IV 476% · EM ±84.3%Sep 01 — IV 495% · EM ±85.3%Sep 02 — IV 591% · EM ±98.8%Sep 03 — IV 622% · EM ±100.6%Sep 04 — IV 618% · EM ±96.5%Sep 09 — IV 873% · EM ±109.4%Sep 10 — IV 1107% · EM ±130.7%Sep 14 — IV 1647% · EM ±137.6%Sep 16 — IV 2680% · EM ±158.3%Sep 21 — IV 838% · EM ±175.0%Sep 22 — IV 660% · EM ±135.1%Sep 23 — IV 396% · EM ±79.3%Sep 25 — IV 840% · EM ±160.7%Sep 29 — IV 902% · EM ±155.2%Sep 30 — IV 939% · EM ±156.9%Oct 01 — IV 1016% · EM ±164.3%Oct 02 — IV 1131% · EM ±176.7%Oct 06 — IV 1328% · EM ±175.4%Oct 07 — IV 1391% · EM ±174.2%

Sector peers

OGI
Organigram Global Inc.
$169M $0.93-1.6%
CNTN
Canton Strategic Holdings, Inc.
$174M $1.86-3.6%
NKTX
Nkarta, Inc.
$183M $1.79+2.3%
CUE
Cue Biopharma, Inc.
$183M $18.66-1.5%
PEPG
PepGen Inc.
$153M $2.52-7.3%
ASRT
Assertio Holdings, Inc.
$151M $23.50

ORGO earnings FAQ

When is ORGO's next earnings date?

Organogenesis Holdings Inc. is expected to report on November 5, 2026.

What is ORGO's expected move for earnings?

Options currently price a move of about ±174.2%, or $1.72 per share either way from $0.99.

How does ORGO stock usually react to earnings?

Across the last 4 reports the average next-day move was ±23.6%, up 2 times and down 2 times.

What is ORGO's implied volatility?

ORGO's at-the-money implied volatility is about 14% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in